OMEPRAX Drossapharm caps 40 mg bte 98 pce

7680659790144 CH-65979 A02BC01 04.99.0.
OMEPRAX Drossapharm caps 40 mg bte 98 pce
OMEPRAX Drossapharm caps 40 mg bte 98 pce
OMEPRAX Drossapharm caps 40 mg bte 98 pce
1 / 3
google

Details

Product number
6597903
CPT
-
Packaging group
98
Unit
Kapsel(n)
Composition
omeprazolum 40 mg, sacchari sphaerae corresp. saccharum 160.05 mg, povidonum K 30, natrii laurilsulfas, carboxymethylamylum natricum A, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, E 171, Kapselhülle: aqua, gelatina, E 171, Drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, E 172 (nigrum), pro capsula corresp. natrium 3.03 mg.

Articles (1)

Omeprax-Drossapharm 40mg, magensaftresistente Kapseln
Magensaftresistente Kapseln
98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/08/2024
Patient information leaflet
Français
12/08/2024
Patient information leaflet
Italien
12/08/2024
Professional SmPC
Allemand
12/08/2024
Professional SmPC
Français
12/08/2024
Professional SmPC
Italien
12/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
160.05 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
3.03 MG Substance HBESI

Reimbursement information

Public price
CHF 70.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2016

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
65979
Drug name
Omeprax-Drossapharm, magensaftresistente Kapseln
Galenic form
KAHAM
ATC Code
A02BC01
Authorization status
Z
Authorization category
Category C
Dispensation category
B
First authorization
04/11/2015
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Zollinger-Ellison-Syndrom

Packaging details

Description (FR)
OMEPRAX Drossapharm caps 40 mg bte 98 pce
Description (DE)
OMEPRAX Drossapharm Kaps 40 mg Ds 98 Stk
Market launch
04/11/2015
Narcotic (BTM)
No

Original drug

Antramups, Tabletten
CHF 16.20
View original

Other packaging sizes

OMEPRAX Drossapharm caps 10 mg bte 14 pce
14 KAP
View
OMEPRAX Drossapharm caps 10 mg bte 28 pce
28 KAP
View
OMEPRAX Drossapharm caps 10 mg bte 56 pce
56 KAP
View
OMEPRAX Drossapharm caps 10 mg bte 98 pce
98 KAP
View
OMEPRAX Drossapharm caps 20 mg bte 7 pce
7 KAP
View
OMEPRAX Drossapharm caps 20 mg bte 14 pce
14 KAP
View
OMEPRAX Drossapharm caps 20 mg bte 28 pce
28 KAP
View
OMEPRAX Drossapharm caps 20 mg bte 56 pce
56 KAP
View
OMEPRAX Drossapharm caps 20 mg bte 98 pce
98 KAP
View
OMEPRAX Drossapharm caps 40 mg bte 7 pce
7 KAP
View